Displaying 201 - 250 of 5627 results
Released Company Title Industry Topic
27 Mar 2024
18:31 CET
VRANKEN-POMMERY VRANKEN-POMMERY MONOPOLE - RESULTATS ANNUELS 2023 - Progression du ROC de 12,7% à 39 M€ 45101015 Distillers and Vintners Income
27 Mar 2024
18:30 CET
WALLIX WALLIX commits to Docaposte for a complete cybersecurity offer for SMEs, communities and health establishments 10101015 Software Legal
27 Mar 2024
18:30 CET
MEMSCAP REGPT Memscap: 2023 Earnings 10102010 Semiconductors Income
27 Mar 2024
18:30 CET
WALLIX WALLIX s'engage auprès de Docaposte pour une offre complète de cybersécurité à destination des PME, collectivités et établissements de santé 10101015 Software Legal
27 Mar 2024
18:30 CET
MEMSCAP REGPT MEMSCAP : RESULTATS ANNUELS 2023 10102010 Semiconductors Income
27 Mar 2024
18:20 CET
TARKETT Tarkett- MISE À DISPOSITION DU DOCUMENT D’ENREGISTREMENT UNIVERSEL 2023 50101035 Building Materials: Other Corporate life
27 Mar 2024
18:20 CET
TARKETT Tarkett- AVAILABILITY OF THE 2023 UNIVERSAL REGISTRATION DOCUMENT 50101035 Building Materials: Other Corporate life
27 Mar 2024
18:06 CET
B.C.P.-BCO COMERCIAL PORTUGUES Corporate Governance Report 2023 30101010 Banks Other subject
27 Mar 2024
18:06 CET
B.C.P.-BCO COMERCIAL PORTUGUES Relatório do Governo Societário 2023 30101010 Banks Other subject
27 Mar 2024
18:06 CET
LNA SANTE LNA SANTE : Annual Results 2023 20101010 Health Care Facilities General meeting / Board Meeting
27 Mar 2024
18:03 CET
HIGH CO HIGHCO : Résultats Annuels 2023 40301020 Media Agencies Income
27 Mar 2024
18:03 CET
HIGH CO HighCo: 2023 annual earnings 40301020 Media Agencies Income
27 Mar 2024
18:01 CET
LNA SANTE LNA SANTE : Résultats annuels 2023 20101010 Health Care Facilities General meeting / Board Meeting
27 Mar 2024
18:01 CET
BIOMERIEUX bioMérieux receives Dual 510(k) clearance and CLIA-waiver approval for the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel 20102010 Medical Equipment Other subject
27 Mar 2024
18:01 CET
BIOMERIEUX bioMérieux obtient l\'agrément 510(k) et la dérogation CLIA pour le panel BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) 20102010 Medical Equipment Other subject
27 Mar 2024
18:00 CET
LEPERMISLIBRE S.A. lePERMISLIBRE publie ses résultats annuels 2023 40201070 Consumer Services: Misc. Commercial results
27 Mar 2024
18:00 CET
LEPERMISLIBRE S.A. lePERMISLIBRE announces its 2023 annual results 40201070 Consumer Services: Misc. Commercial results
27 Mar 2024
18:00 CET
ABIVAX ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 29.02.24. 20103010 Biotechnology Share history
27 Mar 2024
18:00 CET
ENOGIA ENOGIA: 2023 annual results 60102020 Renewable Energy Equipment Income
27 Mar 2024
18:00 CET
ENOGIA ENOGIA: Résultats annuels 2023 60102020 Renewable Energy Equipment Income
27 Mar 2024
18:00 CET
VAN DE VELDE VAN DE VELDE : acquisition of treasury shares 40204020 Clothing and Accessories Other subject
27 Mar 2024
18:00 CET
AMG Critical Materials N.V. AMG Critical Materials N.V. Publishes Agenda for the 2024 Annual General Meeting and Expands Management Board 50204000 Machinery: Industrial -
27 Mar 2024
18:00 CET
EXPLOSIFS PROD.CHI Forte amélioration des résultats, situation financière saine et reprise du dividende 55201000 Chemicals: Diversified Sales, Income, Commercial results
27 Mar 2024
18:00 CET
OSE IMMUNOTHERAPEUTICS OSE Immunotherapeutics Reports Full Year 2023 Financial Results and Provides Business Strategy Update 20103010 Biotechnology Income
27 Mar 2024
18:00 CET
GUILLEMOT GUILLEMOT CORPORATION: 2023 ANNUAL RESULTS 10102030 Computer Hardware General meeting / Board Meeting
27 Mar 2024
18:00 CET
VALEO Valeo General Shareholders' Meeting 2024 40101025 Auto Parts General meeting / Board Meeting
27 Mar 2024
18:00 CET
AZELIS GROUP NV Azelis LTIP Share Buyback Program 2024 – Update 55201000 Chemicals: Diversified Other subject
27 Mar 2024
18:00 CET
AZELIS GROUP NV   Azelis LTIP Aandeleninkoopprogramma 2024 - update 55201000 Chemicals: Diversified Other subject
27 Mar 2024
18:00 CET
HYBRID SOFTWARE GROUP PLC Notification of transactions in shares by persons discharging managerial responsibility ("PDMRs") 10101015 Software Other subject
27 Mar 2024
18:00 CET
SCHLUMBERGER SLB Announces First-Quarter 2024 Results Conference Call 60101030 Oil Equipment and Services Meetings / events
27 Mar 2024
18:00 CET
VAN DE VELDE VAN DE VELDE : inkoop eigen aandelen 40204020 Clothing and Accessories Other subject
27 Mar 2024
18:00 CET
OSE IMMUNOTHERAPEUTICS OSE Immunotherapeutics publie ses résultats financiers annuels 2023 et fait le point sur sa stratégie de développement 20103010 Biotechnology Income
27 Mar 2024
18:00 CET
CONSTRUCTEURS BOIS FORTE CROISSANCE DE L'ACTIVITÉ ET DE LA RENTABILITÉ EN 2023 - RELÈVEMENT DE L'OBJECTIF DE CHIFFRE D'AFFAIRES 2025 50101010 Construction Sales, Income, Commercial results
27 Mar 2024
18:00 CET
VALEO Assemblée générale 2024 de Valeo 40101025 Auto Parts General meeting / Board Meeting
27 Mar 2024
18:00 CET
MEDINCELL S.A. MedinCell to Present at the 23rd Annual Needham Virtual Healthcare Conference 20103010 Biotechnology Corporate life
27 Mar 2024
18:00 CET
GUILLEMOT GUILLEMOT CORPORATION : RESULTATS ANNUELS 2023 10102030 Computer Hardware General meeting / Board Meeting
27 Mar 2024
18:00 CET
MEXEDIA S.P.A Results 2023 30202000 Diversified Financial Services Commercial results
27 Mar 2024
18:00 CET
MEDINCELL S.A. MedinCell participera à la 23ème conférence annuelle Needham Virtual Healthcare 20103010 Biotechnology Corporate life
27 Mar 2024
17:45 CET
INVIBES ADVERTISING N.V. Invibes Advertising : Forte progression des résultats annuels 2023. 40301020 Media Agencies Commercial results
27 Mar 2024
17:45 CET
INVIBES ADVERTISING N.V. Invibes Advertising : Strong growth in annual results 2023. 40301020 Media Agencies Commercial results
27 Mar 2024
17:45 CET
ARGAN ARGAN delivered a 4,600 sq.m, Aut0nom®-labelled distribution centre to DSV in Normandie 35102030 Office REITs New
27 Mar 2024
17:45 CET
INVIBES ADVERTISING N.V. Invibes Advertising : Strong growth in annual results 2023. Return to positive EBITDA and net profit. 40301020 Media Agencies Sales, Income, Commercial results
27 Mar 2024
17:45 CET
KLEPIERRE KLÉPIERRE: AVAILABILITY OF 2023 UNIVERSAL REGISTRATION DOCUMENT 35102045 Retail REITs Other subject
27 Mar 2024
17:45 CET
INVIBES ADVERTISING N.V. Invibes Advertising : Forte progression des résultats annuels 2023. Retour à un EBITDA et à un résultat net positifs. 40301020 Media Agencies Sales, Income, Commercial results
27 Mar 2024
17:45 CET
TRANSGENE Transgene anticipates significant progress from immunotherapy pipeline in 2024 and extends financial visibility until Q4 2025 20103010 Biotechnology Income
27 Mar 2024
17:45 CET
MAUNA KEA TECHNOLOGIES S.A. Mauna Kea Technologies s’associe à V7 pour le développement d’applications innovantes d’IA avec le Cellvizio 20102010 Medical Equipment Alliances and agreements
27 Mar 2024
17:45 CET
TRANSGENE Transgene nomme Lucie Larguier en tant que Directrice Financière et Christelle Schwoerer Comme Directrice des Ressources Humaines 20103010 Biotechnology Journal / appointments
27 Mar 2024
17:45 CET
CEGEDIM Cegedim Full year 2023 results: Revenue and recurring operating income both up 10101010 Computer Services Income
27 Mar 2024
17:45 CET
ARGAN ARGAN livre à DSV une plateforme de distribution de 4 600 m² labellisée Aut0nom® en Normandie 35102030 Office REITs New
27 Mar 2024
17:45 CET
KLEPIERRE KLÉPIERRE: MISE À DISPOSITION DU DOCUMENT D'ENREGISTREMENT UNIVERSEL 2023 35102045 Retail REITs Other subject